TSE:2395Life Sciences
Shin Nippon Biomedical Laboratories (TSE:2395) Stock May Rerate On 4x EPS Growth
Shin Nippon Biomedical Laboratories stock has quietly climbed in recent weeks, yet the real story sits in the earnings line. Q1 FY2027 basic earnings per share of ¥25.56 and net income of ¥1,064.04m landed on top of a trailing twelve month P/E of roughly 11.3x, which is well below both peers and the broader Japanese market. That combination of solid profitability and discounted valuation is the headline. The short term question is how traders treat the latest quarter. The longer term question...